JAN STAHLBERG Insider Profile
4 Followers
JAN STAHLBERG, Ten Percent Owner at Diamedica Therapeutics, holds 8.83M shares in Diamedica Therapeutics (Ticker: DMAC). Most recently, JAN STAHLBERG Bought 1,061,277 shares of Diamedica Therapeutics on Dec 08, 2025 for an estimated value of $7.62M.
JAN STAHLBERG's Trading History
| DMACDiamedica Therapeutics | Dec 08, 2025 | Ten Percent Owner | Informative Buy | 7.62M | $85.26M | |
DMAC Insider Shares: 8.83M (16.95%) | ||||||
You May Also Like
JAN STAHLBERG insider profile FAQ
What is the percentage of profitable transactions made by JAN STAHLBERG?
The percentage of profitable transactions made by JAN STAHLBERG is 100%.
What is the average return per transaction made by JAN STAHLBERG?
The average return per transaction made by JAN STAHLBERG is 21.60%.
What stocks does JAN STAHLBERG hold?
JAN STAHLBERG holds: DMAC stocks.
What was JAN STAHLBERG’s latest transaction?
JAN STAHLBERG’s latest transaction was an Informative Buy of $7.62M.
What was JAN STAHLBERG's most profitable transaction?
JAN STAHLBERG’s most profitable transaction was an Informative Buy of DMAC stock on July 25, 2025. The return on the trade was 33.30%.
What is JAN STAHLBERG's role in Diamedica Therapeutics?
JAN STAHLBERG's role in Diamedica Therapeutics is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
